본문 바로가기(Skip Contents)
ENGLISH
KOREAN
HOME
ABOUT US
Overview
History
Manufacturing facility
Our Company
PRODUCT
ALS (NeuroNata-R®)
Lou Gehrig's disease
PIPELINE
Pipeline
SLE
CA
R&D
Stem Cell Therapy
IR
Stock Information
Disclosures
Finances
Announcement of Settlement
IR Inquiry
PR
Press Report
Notice
Media
Online Inquiry
전체메뉴
전체메뉴
ABOUT US
Overview
History
Manufacturing facility
Our Company
PRODUCT
ALS (NeuroNata-R®)
Lou Gehrig's disease
PIPELINE
Pipeline
SLE
CA
R&D
Stem Cell Therapy
IR
Stock Information
Disclosures
Finances
Announcement of Settlement
IR Inquiry
PR
Press Report
Notice
Media
Online Inquiry
HOME
ENGLISH
KOREAN
ABOUT US
Overview
History
Manufacturing facility
Our Company
PRODUCT
ALS (NeuroNata-R®)
Lou Gehrig's disease
PIPELINE
Pipeline
Target Disease
Lupus
R&D
Stem Cell Therapy
IR
Stock Information
Disclosures
Finances
Announcement of Settlement
IR Inquiry
PR
Press Report
Notice
Media
Online Inquiry
PR
Corestem is a biopharmaceutical company that
researches and commercializes stem cell technology.
Press Report
Notice
Media
Online Inquiry
Press Report
Notice
Media
Online Inquiry
공지사항
17
2022.03
코아스템 사업 보고서
READ MORE
17
2022.03
코아스템 감사보고서
READ MORE
11
2022.03
대표이사 서한 및 주요 경영사항 보고
READ MORE
24
2020.07
[공지사항] Neuronata-R FDA 임상 3상 승인
READ MORE
19
2020.03
공지 사항 - 미국 식품식약처 (FDA) IND 승인 여부의건
READ MORE
1
2
3
4